RecruitingNCT01772602

The National Amyotrophic Lateral Sclerosis Registry


Sponsor

Centers for Disease Control and Prevention

Enrollment

30,000 participants

Start Date

Oct 1, 2010

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this registry is to (A) better describe the incidence and prevalence of Amyotrophic Lateral Sclerosis (ALS) in the United States;(B) examine appropriate factors, such as environmental and occupational, that may be associated with the disease; (C) better outline key demographic factors (such as age, race or ethnicity, gender, and family history of individuals who are diagnosed with the disease) associated with the disease; and (D) better examine the connection between ALS and other motor neuron disorders that can be confused with ALS, misdiagnosed as ALS, and in some cases progress to ALS.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • \- U.S. citizens 18 years of age or older

Exclusion Criteria1

  • \-

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

CDC

Atlanta, Georgia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01772602


Related Trials